| 1 |
28084011 | Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells. | 2017 Mar |
2 |
| 2 |
26959741 | SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma. | 2016 Apr 19 |
3 |
| 3 |
27580057 | Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer. | 2016 Sep 27 |
2 |
| 4 |
26039995 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition. | 2015 Jun 9 |
2 |
| 5 |
23908138 | Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma. | 2014 Jan |
13 |
| 6 |
24275147 | SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model. | 2014 Jan |
1 |
| 7 |
24736071 | Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer. | 2014 Apr |
2 |
| 8 |
23938089 | Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells. | 2013 |
3 |
| 9 |
22871485 | Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity. | 2012 Sep |
2 |